- Nada Wigand
Pathology Grand Rounds provides continuing education and professional development for faculty in the Department of Pathology and related disciplines. Lecture topics encompass a wide range of pathology disciplines including surgical pathology, autopsy pathology, chemical pathology, transfusion medicine, and many more. The series offers opportunities for productive interdisciplinary learning between pathology faculty, clinical providers, and technical personnel.
The primary target audience is faculty physician pathologists (MD/DO) at UW. Non‐UW pathologists and students may also benefit from the RSS. Nonpathology physicians will benefit from topics within their area of expertise, such as infectious disease specialists learning about MALDITOF diagnostics.
Thomas Raife, MD, Chair
Nada Wigand, Coordinator
Erik Ranheim, MD, PhD
|In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.|
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity, all relevant financial relationships have been mitigated and detailed disclosures are listed below.
* Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
Detailed disclosures will be available prior to the start of the activity.
As a result of participation in this educational series, learners will be able to:
- Identify emerging diagnostic schemes, disease classification schemes, technological advances, such as the principles of MALDI-TOF as it applies to the microbiology, in order to effectively manage cases.
- Use appropriate technology, protocols and workflows in order to optimize the quality and accuracy of pathology services and diagnoses.
- Develop an appreciation of the roles and responsibilities of members of the interdisciplinary pathology team.